1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(pyridin-4-yloxy)phenyl)urea

Catalog No.: 
ACPNRF382
CAS No.: 
228400-44-0
Molecular Formula: 
C19H13ClF3N3O2
Molecular Weight: 
407.78
1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(pyridin-4-yloxy)phenyl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$959.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(pyridin-4-yloxy)phenyl)urea
IUPAC Name1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-(pyridin-4-yloxy)phenyl)urea
Molecular FormulaC19H13ClF3N3O2
Molecular Weight407.78
SMILESO=C(NC1=CC=C(Cl)C(C(F)(F)F)=C1)NC2=CC=C(OC3=CC=NC=C3)C=C2
InChI KeyXMBRISOLVGBCBC-UHFFFAOYSA-N
SynonymUrea, N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-[4-(4-pyridinyloxy)phenyl]-;3-[4-chloro-3-(trifluoromethyl)phenyl]-1-[4-(pyridin -4-yloxy)phenyl]urea
CAS No.228400-44-0

Synthetic Route by SureRoute

1. ACPNRF382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWGLE728 route compound structure diagram
    ACWGLE728102877-78-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPNRF382 route product structure diagram
    ACPNRF382228400-44-0
Inquiry

2. ACPNRF382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCDI495 route compound structure diagram
    ACBCDI495320-51-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPNRF382 route product structure diagram
    ACPNRF382228400-44-0
Inquiry

3. ACPNRF382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOZRV135 route compound structure diagram
    ACOZRV13519524-06-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPNRF382 route product structure diagram
    ACPNRF382228400-44-0
Inquiry

Comments (0)